The base of
osteoporosis is an imbalance of bone remodeling processes, with a predominance of the resorption phase that in the maxillofacial region is manifested by a partial and complete absence of teeth with a decrease in the volume of bone tissue of the jaws and a violation of its microarchitectonics.
Atrophy of the alveolar bone reduces the degree of fixation of the removable
prosthesis, can develop various diseases of the underlying mucosa. In this regard, the installation of
dental implants as a support for removable orthopedic structures is relevant, however, in patients with
osteoporosis, the risk of complications in the early and late postoperative period remains high to 44%. Objective: to improve the efficiency of
dental implantation in patients with
osteoporosis. 80 men over 50 years old with complete absence of teeth on the lower jaw with alveolar
atrophy and
osteoporosis were under observation. Carried out condition monitoring of the micro alveolar bone in patients with
osteoporosis without a comprehensive antiosteoporotic
therapy and in patients receiving
ibandronate for 1
tablet (150 mg), 1 time a month with
calcium 1 000 mg and
vitamin D (
cholecalciferol) 800 IU daily. It was found that taking antiresorptive
therapy for 3 months improves the quality of the alveolar bone, increases the effectiveness of
dental implantation in patients with complete absence of teeth and
atrophy of the alveolar part.